Home Top Movers Moleculin Biotech, Inc. (MBRX) stock is rising today: What’s Going on?

Moleculin Biotech, Inc. (MBRX) stock is rising today: What’s Going on?

Moleculin Biotech, Inc. (MBRX) announced today that it has been granted Rare Pediatric Disease Designation (RPD) for WP1066 to treat ependymoma after which the MBRX stock price saw an uptrend of 7.18% to reach $4.16 a share at the time of this writing. MBRX stock was also green in the previous trading session and went up by 0.56% at closing. Let’s understand more about MBRX stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Rare Pediatric Disease Designation:

Moleculin Biotech, Inc is a clinical-stage company working on the development of oncology drugs in order to treat patients suffering from highly resistant tumors and viruses in the U.S.Investors are responding to the news announced by the MBRX stock today related to its p-STAT3 inhibitor, WP1066 which is used to treat ependymoma. Ependymoma is a rare tumor that usually forms in the brain and spinal cord and occurs at any age but usually occurs in young children.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

Moleculin stock would be able to receive the voucher in connection with the FDA approval of WP1066 which then may be redeemed to receive the priority review for a subsequent marketing application for other product candidates. The MBRX stock can also sell or transfer that voucher.

Management Viewpoint:

Management thinks that the Rare Pediatric Disease Designation grant by FDA for WP1066 is the major milestone. Management is looking forward to the expansion and development of WP1066 in the future and firmly believes that the WP1066 has the great potential to treat pediatric patients suffering from ependymoma.

Rare Pediatric Disease

Rare Pediatric Disease a serious life-threatening disease that usually targets individuals aged from birth to 18 years. Nearly 200,000 people are affected by this disease in the United States of America.

Previous News of MBRX stock:

On April 6, 2021, Moleculin stock did announce the engagement of  IQVIA Biotech in order to manage the potential clinical trials of WP1122 by the MBRX stock to treat COVID-19. The purpose of this engagement is to check the potential of  WP1122 against the deadly pandemic.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

So far so good for MBRX as far as market sentiment is concerned. It seems that momentum was already building for MBRX stock and recent news has added more hype to the rising stock price of Moleculin stock. Recent developments point to the growth of MBRX stock but a deep fundamental, as well as technical analysis, is recommended for this stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?

In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. Get...

Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know

Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price...

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge...

What Is Driving The Powerbridge (PBTS) Stock Higher In Premarket session?

At the last check, Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) shares were rising 10.71% to trade at $1.55 in premarket trades. The Powerbridge stock...

Beyond Meat, Inc. (BYND) Stock Trending Down After Management’s Uncertainty Over Fiscal Year Guidelines

Beyond Meat, Inc. (BYND) stock prices were down by 2.08% as of the market closing on May 6th, 2021, bringing the price per share...

Regional Health Properties, Inc. (RHE) Stock Skyrockets Following Trading of Exponential Volume of Shares

Regional Health Properties, Inc. (RHE) stock prices soared by 31.4% during early market hours on May 7th 2021, bringing the price per share up...

Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced

Orphazyme A/S (ORPH) stock prices plummeted by 27.77%  after the market opened on May 7th, 2021, bringing the price per share tumbling down to...

Avalon Holdings Corporation (NYSE:AWX) stock surged in the current trading session; here’s why

At last check, in the current trading session, AWX stock surged by 22.58% to $5.08. AWX stock previously closed the session at $4.14. The...

Related News

Epizyme, Inc. (EPZM) Stock Experiences Volatility Following Disclosure of Q1 2021 Financial Reports

Epizyme, Inc. (EPZM) stock prices were down by 9.44% as of the market closing on May 6th 2021, bringing the price per share down...

Angi Inc. (NASDAQ:ANGI) stock surged in the premarket trading session; here’s why

In the premarket session, Angi Inc. (ANGI) stock surged by 9.69% to $15 at last check. ANGI stock closed previous session at $14.04. The...

CureVac Inc. (NASDAQ: CVAC) stock rises during pre-market. Here’s what’s happening?

CureVac Inc. (NASDAQ: CVAC) stock declined by 7.16% at last close whereas the CVAC stock price gains by 8.44% in the pre-market trading session....

Obalon Therapeutics, Inc. (OBLN) Stock Undergoes Volatility as Pandemic Regulations Relaxed

Obalon Therapeutics, Inc. (OBLN) stock prices were down by 15.13% as of the market closing on May 6th, 2021, bringing the price per share...

Is This Why Nkarta (NKTX) Stock Rises Premarket?

In premarket trading, shares of biopharmaceutical company developing engineered NK cell therapies to treat cancer Nkarta Inc. (NASDAQ: NKTX) rose 14.62% to $29.71 at...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.